> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Update on Baxter Recall of Hemodialysis Transfer Sets
- URL: https://www.fdaweb.com/update-on-baxter-recall-of-hemodialysis-transfer-sets/
- Published: 2024-12-09T12:00:00.000Z
- Updated: 2026-09-14T14:48:56.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5158323

FDA is updating a Baxter recall (device correction) of its MiniCap Extended Life PD Transfer Sets used in hemodialysis based on recent recalls by other manufacturers related to the potential risk of exposure to non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) and NDL polychlorinated biphenyls (PCBs) when using certain peritoneal dialysis and hemodialysis devices. The [update](https://www.fda.gov/medical-devices/letters-health-care-providers/update-potential-risk-exposure-toxic-compounds-when-using-hemodialysis-and-peritoneal-dialysis?ref=fdaweb.com) says Baxter is “evaluating whether the source of PCBAs and NDL PCBs in those recalls (the silicone tubing manufacturing process using a chlorinated peroxide initiator) is present in MiniCap Extended Life PD Transfer Sets.” Additionally, the company is transitioning certain components in the device sets from peroxide-cured silicone tubing to platinum-cured silicone tubing. “NDL PCBAs and NDL PCBs are not detected in medical devices with this modified version of silicone tubing,” the update says.

“The use of affected product may cause serious adverse health consequences months to years after exposure, including endocrine dysfunction, liver issues, neurobehavioral changes, skin problems (acne, rashes), male infertility, and death,” the notice says. To date, there have been no reported injuries or deaths.